{
    "id": "915bde4c-a9ec-4e3d-b0d2-7b10c93230dc",
    "indications": {
        "text": "zoryve topical foam , 0.3 % , phosphodiesterase 4 inhibitor indicated treatment seborrheic dermatitis adult pediatric patients 9 years age older . ( 1.1 ) plaque psoriasis scalp body adult pediatric patients 12 years age older . ( 1.2 )",
        "doid_entities": [
            {
                "text": "seborrheic dermatitis (DOID:8741)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8741"
            },
            {
                "text": "dermatitis (DOID:2723)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_2723"
            },
            {
                "text": "psoriasis (DOID:8893)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8893"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "shake prior . apply thin layer zoryve foam , 0.3 % , daily affected areas body and/or scalp wet . rub completely . wash hands application . avoid fire , flame , smoking immediately following application [ ( 5.1 ) ] . zoryve foam , 0.3 % , topical ophthalmic , oral , intravaginal .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "adverseReactions": "zoryve foam , 0.3 % , contraindicated patients moderate severe liver impairment ( child-pugh b c ) [ ( 8.6 ) , pharmacology ( 12.3 ) ] .",
    "ingredients": [
        {
            "name": "roflumilast",
            "code": "0P6C6ZOP5U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_47657"
        },
        {
            "name": "ceteareth-10 phosphate",
            "code": "099WOY1SA3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26020"
        },
        {
            "name": "CETOSTEARYL ALCOHOL",
            "code": "2DMT128M1S",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "cetearyl phosphate",
            "code": "4O6GCK4CTJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26020"
        },
        {
            "name": "diethylene glycol monoethyl ether",
            "code": "A1A1I8X02B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_40572"
        },
        {
            "name": "hexylene glycol",
            "code": "KEH0A3F75J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "isopropyl palmitate",
            "code": "8CRQ2TH63M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_84262"
        },
        {
            "name": "methylparaben",
            "code": "A2I8C7HI9T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31835"
        },
        {
            "name": "propylparaben",
            "code": "Z8IX2SC1OH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32063"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "sodium hydroxide",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "white petrolatum",
            "code": "B6E5W8RQJ4"
        },
        {
            "name": "hydrochloric acid",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "butane",
            "code": "6LV4FOR43R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37808"
        },
        {
            "name": "isobutane",
            "code": "BXR49TP611",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30363"
        },
        {
            "name": "propane",
            "code": "T75W9911L6",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32879"
        }
    ],
    "organization": "Arcutis Biotherapeutics, Inc.",
    "name": "ZORYVE",
    "effectiveTime": "20250527",
    "indications_original": "ZORYVE topical foam, 0.3%, is a phosphodiesterase 4 inhibitor indicated for the treatment of seborrheic dermatitis in adult and pediatric patients 9 years of age and older. ( 1.1 ) plaque psoriasis of the scalp and body in adult and pediatric patients 12 years of age and older. ( 1.2 )",
    "contraindications_original": "Shake can prior to each use. Apply a thin layer of ZORYVE foam, 0.3%, once daily to affected areas of body and/or scalp when they are not wet. Rub in completely.\n                  Wash hands after application.\n                  Avoid fire, flame, and smoking during and immediately following application [see Warnings and Precautions (5.1)].\n                  ZORYVE foam, 0.3%, is for topical use only and not for ophthalmic, oral, or intravaginal use.",
    "adverseReactions_original": "ZORYVE foam, 0.3%, is contraindicated in patients with moderate to severe liver impairment (Child-Pugh B or C) [see Use in Specific Populations (8.6), Clinical Pharmacology (12.3)].",
    "drug": [
        {
            "name": "ZORYVE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_47657"
        }
    ]
}